Could Vaccine Misinformation Lead to a Worldwide Health Crisis? 24/08/2024 Maayan Hoffman How did vaccines, once hailed as essential tools for global peace, security and international cooperation, become something that some now fear could kill them? This is the focus of the latest episode of the Global Health Matters podcast, hosted by Garry Aslnyan. In an interview with author Peter Hotez, the discussion delves into how misinformation […] Continue reading -> WHO Report: COVID Eliminated a decade of progress in life expectancy 24/05/2024 Disha Shetty The COVID pandemic has wiped off a decade of steady gain in life expectancy at birth and healthy life expectancy at birth (HALE), according to the World Health Statistics 2024 report by the World Health Organization (WHO). In the light of the findings the world health body has urged countries to redouble their efforts towards […] Continue reading -> Next Pandemic Needs to ‘Focus More on Therapeutics’ 23/05/2024 Kerry Cullinan During the COVID-19 pandemic, therapeutic development took a backseat to vaccines – a potentially disastrous gamble had vaccines not been found. In future pandemics, therapeutics and vaccines should be treated equally – particularly as COVID-19 treatment options remain expensive and mostly only available in high-income countries, speakers told at a webinar this week hosted by […] Continue reading -> Moderna’s Outsized Price Ask for COVID Vaccines in South Africa Highlights Need to ‘Rein in Corporates’ in Pandemics 22/05/2024 Kerry Cullinan CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading -> Empowering Global Health Reporting: Perspectives from Leading Journalists 13/04/2024 Maayan Hoffman Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Report: COVID Eliminated a decade of progress in life expectancy 24/05/2024 Disha Shetty The COVID pandemic has wiped off a decade of steady gain in life expectancy at birth and healthy life expectancy at birth (HALE), according to the World Health Statistics 2024 report by the World Health Organization (WHO). In the light of the findings the world health body has urged countries to redouble their efforts towards […] Continue reading -> Next Pandemic Needs to ‘Focus More on Therapeutics’ 23/05/2024 Kerry Cullinan During the COVID-19 pandemic, therapeutic development took a backseat to vaccines – a potentially disastrous gamble had vaccines not been found. In future pandemics, therapeutics and vaccines should be treated equally – particularly as COVID-19 treatment options remain expensive and mostly only available in high-income countries, speakers told at a webinar this week hosted by […] Continue reading -> Moderna’s Outsized Price Ask for COVID Vaccines in South Africa Highlights Need to ‘Rein in Corporates’ in Pandemics 22/05/2024 Kerry Cullinan CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading -> Empowering Global Health Reporting: Perspectives from Leading Journalists 13/04/2024 Maayan Hoffman Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Next Pandemic Needs to ‘Focus More on Therapeutics’ 23/05/2024 Kerry Cullinan During the COVID-19 pandemic, therapeutic development took a backseat to vaccines – a potentially disastrous gamble had vaccines not been found. In future pandemics, therapeutics and vaccines should be treated equally – particularly as COVID-19 treatment options remain expensive and mostly only available in high-income countries, speakers told at a webinar this week hosted by […] Continue reading -> Moderna’s Outsized Price Ask for COVID Vaccines in South Africa Highlights Need to ‘Rein in Corporates’ in Pandemics 22/05/2024 Kerry Cullinan CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading -> Empowering Global Health Reporting: Perspectives from Leading Journalists 13/04/2024 Maayan Hoffman Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna’s Outsized Price Ask for COVID Vaccines in South Africa Highlights Need to ‘Rein in Corporates’ in Pandemics 22/05/2024 Kerry Cullinan CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading -> Empowering Global Health Reporting: Perspectives from Leading Journalists 13/04/2024 Maayan Hoffman Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Empowering Global Health Reporting: Perspectives from Leading Journalists 13/04/2024 Maayan Hoffman Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Challenging the Status Quo: Six Steps Towards Empowering Communities in Global Health 23/03/2024 Maayan Hoffman What actions and strategies are required for countries and communities to have more agency in their health? This is the topic of the latest episode of the Global Health Matters “Dialogues” podcast series, in which host Dr. Garry Aslanyan tries to “blow up some of the echo chambers that exist in global health.” In this […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Posts navigation Older posts